DENTSPLY SIRONA (NASDAQ: XRAY) SVP awarded stock and phantom units

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. reported that senior vice president and chief human resources officer Andrea L. Frohning acquired additional equity-linked awards on January 9, 2026. She received 392.387 shares of common stock at a price of $0, described as dividends on restricted stock units that are credited as additional RSUs and vest on the same schedule as the underlying awards. After this, she beneficially owned 34,002.252 shares of common stock directly.

Frohning also acquired 22.7283 shares of phantom stock at $12.22 per unit under a Supplemental Executive Retirement Plan, bringing her total phantom stock holdings to 1,759.2738 units. Each phantom stock unit and each RSU is economically equivalent to one share of common stock, with phantom stock payable in common stock upon her termination of employment and RSUs converting into common stock on a 1:1 basis at vesting.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Frohning Andrea L.

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28277

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, CHRO

3. Date of Earliest Transaction (Month/Day/Year)
01/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/09/2026		A		392.387(1)	A	$0	34,002.252	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock (Supplemental Executive Retirement Plan) SERP	(2)	01/09/2026		A		22.7283(3)		(2)	(2)	Common Stock	22.7283	$12.22	1,759.2738	D

Explanation of Responses:

1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

2. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting persons termination of employment.

3. Comprised of phantom stock acquired as a result of accrued dividends.

	/s/ Jessica Nielsen Causey, Attorney-in-Fact for Andrea Frohning	01/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did DENTSPLY SIRONA (XRAY) report for Andrea Frohning?

The company reported that Andrea L. Frohning, its SVP and CHRO, acquired additional common stock and phantom stock units on January 9, 2026 through dividend-related credits on existing awards.

How many DENTSPLY SIRONA (XRAY) common shares did Andrea Frohning acquire?

She acquired 392.387 shares of common stock at a price of $0, representing dividends on her restricted stock units that were credited as additional RSUs.

What is Andrea Frohning’s total DENTSPLY SIRONA (XRAY) common stock ownership after this Form 4?

Following the reported transaction, Andrea Frohning beneficially owned 34,002.252 shares of common stock, held directly.

What phantom stock transaction was reported for DENTSPLY SIRONA (XRAY) SVP Andrea Frohning?

She acquired 22.7283 phantom stock units under a Supplemental Executive Retirement Plan at $12.22 per unit, increasing her phantom stock holdings to 1,759.2738 units.

How do Andrea Frohning’s DENTSPLY SIRONA (XRAY) RSUs and phantom stock convert into common shares?

Each restricted stock unit (RSU) converts into one share of common stock at vesting. Each phantom stock unit is economically equivalent to one share and becomes payable in common stock upon her termination of employment.

Were these DENTSPLY SIRONA (XRAY) insider awards related to dividends?

Yes. The 392.387 common shares arose from dividends on RSUs credited as additional RSUs, and the 22.7283 phantom stock units were described as acquired from accrued dividends.